报价个股详情公司资料公司介绍董事高管财务分析主营构成关键指标财务报表多维分析 公司估值资金追踪卖空分析 公司概况 更多 Fluidigm公司从事生命科学研究生物技术工具的开发、制造和营销。它销售用于质谱分析、聚合酶链式反应、文库准备、单细胞基因组学的预备和分析仪器；以及包括集成流控电路(IFC)、分析和试剂在内的消耗品。该公司由Stephen R.Quake和Gajus V.Worthington于1999年5月19日创立，总部设在加利福尼亚州旧金山南部。 CEO： Linthwaite, Stephen Christopher所属市场： 纳斯达克富途热股榜港股美股沪深交易热度搜索热度资讯热度名称代码最新价涨跌幅暂无内容自选暂无股票立即添加富途牛牛 行情 FLDM Fluidigm Corp. 个股详情FLDM Fluidigm Corp.添加自选6.700-0.210-3.04% 休市中 08/13 19:17:56 美东时间 限时赠送价值5000港元/年的高级行情，解锁更多报价数据马上抢最高6.950今开6.950成交额357.47万最低6.560昨收6.910成交量53.56万股总市值5.10亿市盈率TTM亏损52周最高12.450总股本7616.70万市盈率(静)亏损52周最低3.710港股市值3.53亿委比0.00%历史最高49.455港股股本5267.30万量比0.81历史最低1.170股息TTM--股息LFY3500市净率4.66股息率TTM--股息率LFY52238.81%换手率1.02%振幅5.64%平均价6.673每手1股流通值3.53亿委比0.00%历史最高49.455流通股5267.30万量比0.81历史最低1.170股息TTM--市净率4.66股息率TTM--换手率1.02%振幅5.64%平均价6.673每手1股分时5日日K周K月K季K年K走势预测暂无内容资讯新闻公告研报Fluidigm Option Alert: Jan 21 $7.5 Calls Sweep (37) near the Ask: 530 @ $0.9 vs 588 OI; Ref=$6.67Fluidigm Option Alert: Jan 21 $7.5 Calls Sweep (37) near the Ask: 530 @ $0.9 vs 588 OI; Ref=$6.6701:30Fluidigm Q2 Earnings Ahead Of Street Expectations, But Sees Lower Revenues From COVID-19 ProductsFluidigm Corp\'s (NASDAQ:FLDM) second-quarter revenues grew 19% Y/Y to $31 million, edging out analysts\' average expectation of $30.57 million.Base product and service revenue excluding COVID-19 testin08-06 18:2812 Health Care Stocks Moving In Thursday\'s After-Market SessionGainers Sensus Healthcare (NASDAQ:SRTS) shares moved upwards by 18.07% to $4.18 during Thursday\'s after-market session. This security traded at a volume of 74.2K shares come close, making up 159.42% o08-06 04:31Fluidigm Sees Q3 Sales $29M-$31M vs. $33.92M Est., FY21 Sales $134M-$140M Vs. $135.43M Est.Fluidigm Sees Q3 Sales $29M-$31M vs. $33.92M Est., FY21 Sales $134M-$140M Vs. $135.43M Est.08-06 04:17Fluidigm Q2 EPS $(0.12) Beats $(0.20) Estimate, Sales $31.00M Beat $30.57M EstimateFluidigm (NASDAQ:FLDM) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.20) by 40 percent. This is a 71.43 percent decrease over losses of $(0.07) per sh08-06 04:15Fluidigm 2Q Loss/Shr 23c FLDM *DJ Fluidigm 2Q Loss/Shr 23c FLDM (MORE TO FOLLOW) Dow Jones Newswires August 05, 2021 16:05 ET (20:05 GMT) Copyright (c) 2021 Dow Jones amp; Company, Inc. 08-06 04:05BRIEF-Fluidigm Announced Collaboration Co-Marketing Agreement With ImaBiotech Aug 5 (Reuters) - Fluidigm Corp :   * FLUIDIGM - ANNOUNCED COLLABORATION amp; CO-MARKETING AGREEMENT WITH IMABIOTECH FOR SERVICE OFFERINGS AND PRODUCT DEVELOPMENT FOR IMAGING MASS CYTOMETRYSou08-05 22:33Fluidigm Reports Co-Marketing Deal With Ultivue For Biomarker Imaging Solutions For Precision Medicine, No Terms DisclosedFluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a co-marketing agreement with Ultivue08-05 20:38Avadel Pharma ADRs Rise Premarket After FDA Accepts NDA for FT218 DJ Avadel Pharma ADRs Rise Premarket After FDA Accepts NDA for FT218 By Robb M. Stewart Avadel Pharmaceuticals PLC\'s American depositary receipts jumped ahead of the bell Monday after the U.S.03-01 21:55Fluidigm shares are trading higher. Not seeing any company-specific news to justify the price action.Fluidigm shares are trading higher. Not seeing any company-specific news to justify the price action.02-18 02:19